findmyKOL
Clinical trialNCT07434973Not, yet, recruitingPhase 3Interventional

Stratification and Treatment in Early Psychosis Study - PROMOTE

SponsorUniversity of OxfordEnrollment586Clinical High Risk for Developing PsychosisClinical High Risk for PsychosisClinical High Risk for Psychosis (CHR)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Meduni Vienna, Department of Child and Adolescent Psychiatry

    Vienna, Austria

    Christian Scharinger
Canada
  • Douglas Hospital Research Centre

    Montreal, Canada

    Simon Ducharme
Finland
  • University Hospital Turku

    Turku, Finland

    Jarmo Hietala
Germany
  • Vivantes Network for Health Gmbh

    Berlin, Germany

    Andreas Bechdolf
  • University of Cologne, Faculty of Medicine and University Hospital of Cologne

    Cologne, Germany

    Joseph Kambeitz
  • University Medical Center Schleswig-Holstein

    Lübeck, Germany

    Stefan Borgwardt
  • Ludwig Maximilian University Hospital

    München, Germany

    Nikolaos Koutsouleris
Greece
  • National and Kapodistrian University of Athens

    Athens, Greece

    Nikos Stefanis
Italy
  • University of Bari Aldo Moro

    Bari, Italy

    Alessandro Bertolino
  • University of Campania L. Vanvitelli

    Naples, Italy

    Armida Mucci
  • University of Pavia

    Pavia, Italy

    Paolo Fusar-Poli
  • Irccs Santa Lucia Foundation

    Roma, Italy

    Clelia Pellicano
Netherlands
  • Stichting Amsterdam Umc

    Amsterdam, Netherlands

    Lieuwe de Haan
Spain
  • Biobizkaia Health Research Institute (asociación Instituto de Investigación Sanitaria)

    Bilbao, Spain

    Ana Catalan
  • Foundation for Biomedical Research of the Gregorio Marañón Hospital (fibhgm)

    Madrid, Spain

    Celso Arango
Switzerland
  • Psychiatric University Hospital (puk)

    Zurich, Switzerland

    Philipp Homan
United Kingdom
  • Cambridgeshire and Peterborough Nhs Foundation Trust

    Cambridge, United Kingdom

  • Institute of Psychiatry, Psychology & Neuroscience, King'S College London

    London, United Kingdom

    Paolo Fusar-Poli
  • Oxford Health Nhs Foundation Trust (ohft)

    Oxford, United Kingdom

    Belinda Lennox

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 May 2026
Primary completion
1 Dec 2029
Completion
1 Dec 2031
Last update posted
27 Feb 2026
Registered enrollment
586
Registry id
NCT07434973

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.